Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00789958 · OUTCOME

2-year Stratum-specific Disease-free Survival

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct · Source last updated 2018-04-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
Up to 2 years from registration

What was measured

Disease-free survival is calculated from date of registration to date of first documentation of relapse or death due to any cause. Patients last known to be alive are censored at date of last contact.

Analysis population: Eligible and analyzable patients that received protocol treatment.

Groups in this outcome

Patients With Negative Margins of Resection (R0)

Eligible and analyzable patients that received a resection with negative (R0) margins.

Patients w/Microscopically Positive Margin of Resection (R1)

Eligible and analyzable patients that received a resection with microscopically positive (R1) margins.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Patients With Negative Margins of Resection (R0)54
Patients w/Microscopically Positive Margin of Resection (R1)25

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Patients With Negative Margins of Resection (R0)54Not reported4066Not reported
Patients w/Microscopically Positive Margin of Resection (R1)48Not reported2765Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        40
        upper Limit
        66
        value
        54
      2. group Id
        OG001
        lower Limit
        27
        upper Limit
        65
        value
        48
denoms
  1. counts
    1. group Id
      OG000
      value
      54
    2. group Id
      OG001
      value
      25
    units
    Participants
description
Disease-free survival is calculated from date of registration to date of first documentation of relapse or death due to any cause. Patients last known to be alive are censored at date of last contact.
dispersion Type
95% Confidence Interval
groups
  1. description
    Eligible and analyzable patients that received a resection with negative (R0) margins.
    id
    OG000
    title
    Patients With Negative Margins of Resection (R0)
  2. description
    Eligible and analyzable patients that received a resection with microscopically positive (R1) margins.
    id
    OG001
    title
    Patients w/Microscopically Positive Margin of Resection (R1)
param Type
NUMBER
population Description
Eligible and analyzable patients that received protocol treatment.
reporting Status
POSTED
time Frame
Up to 2 years from registration
title
2-year Stratum-specific Disease-free Survival
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice